He SB - Search Results

1

SIRT3 expression in hepatocellular carcinoma and its impact on proliferation and invasion of hepatoma cells.

Zhang B, Qin L, Zhou CJ, Liu YL, Qian HX, He SB. Zhang B, et al. Among authors: he sb. Asian Pac J Trop Med. 2013 Aug;6(8):649-52. doi: 10.1016/S1995-7645(13)60112-1. Asian Pac J Trop Med. 2013. PMID: 23790338 Free article.

2

Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.

Zhi Q, Zhu J, Guo X, He S, Xue X, Zhou J, Hu B, Li H, Chen S, Zhao H, Kuang Y. Zhi Q, et al. Biomed Pharmacother. 2013 Jun;67(5):393-8. doi: 10.1016/j.biopha.2013.03.022. Epub 2013 Apr 18. Biomed Pharmacother. 2013. PMID: 23648054

3

Effect of CLN3 silencing by RNA interference on the proliferation and apoptosis of human colorectal cancer cells.

Zhu X, Huang Z, Chen Y, Zhou J, Hu S, Zhi Q, Song S, Wang Y, Wan D, Gu W, Zhou H, Zhang B, Cao W, He S. Zhu X, et al. Biomed Pharmacother. 2014 Apr;68(3):253-8. doi: 10.1016/j.biopha.2013.12.010. Epub 2014 Jan 15. Biomed Pharmacother. 2014. PMID: 24556023

4

Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma.

Yuan R, Zhi Q, Zhao H, Han Y, Gao L, Wang B, Kou Z, Guo Z, He S, Xue X, Hu H. Yuan R, et al. Tumour Biol. 2015 Apr;36(4):3093-100. doi: 10.1007/s13277-014-2945-2. Epub 2014 Dec 16. Tumour Biol. 2015. PMID: 25510666

5

miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC.

Wan D, Shen S, Fu S, Preston B, Brandon C, He S, Shen C, Wu J, Wang S, Xie W, Chen B, Liya A, Guo Y, Zheng D, Zhi Q, Peng B. Wan D, et al. Anticancer Agents Med Chem. 2016;16(4):414-23. doi: 10.2174/1871520615666150716105955. Anticancer Agents Med Chem. 2016. PMID: 26179263

6

Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells.

He SB, Yuan Y, Wang L, Yu MJ, Zhu YB, Zhu XG. He SB, et al. J Exp Clin Cancer Res. 2011 Nov 22;30(1):109. doi: 10.1186/1756-9966-30-109. J Exp Clin Cancer Res. 2011. PMID: 22104393 Free PMC article.

7

Expression of the co-signaling molecules CD40-CD40L and their growth inhibitory effect on pancreatic cancer in vitro.

He S, Zhao H, Fei M, Wu Y, Wang L, Zhu X, Li D. He S, et al. Oncol Rep. 2012 Jul;28(1):262-8. doi: 10.3892/or.2012.1790. Epub 2012 Apr 26. Oncol Rep. 2012. PMID: 22552529

8

Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers.

Wan D, He S, Xie B, Xu G, Gu W, Shen C, Hu Y, Wang X, Zhi Q, Wang L. Wan D, et al. Med Oncol. 2013 Mar;30(1):378. doi: 10.1007/s12032-012-0378-6. Epub 2013 Jan 6. Med Oncol. 2013. PMID: 23292866

9

Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells.

Liu PF, Wu YY, Hu Y, Wang L, He SB, Zhu YB, Zhu XG. Liu PF, et al. Among authors: he sb. Oncol Rep. 2013 Jul;30(1):213-20. doi: 10.3892/or.2013.2478. Epub 2013 May 15. Oncol Rep. 2013. PMID: 23677445

10

Adenovirus-mediated ING4 expression reduces multidrug resistance of human gastric carcinoma cells in vitro and in vivo.

Mao ZL, He SB, Sheng WH, Dong XQ, Yang JC. Mao ZL, et al. Among authors: he sb. Oncol Rep. 2013 Nov;30(5):2187-94. doi: 10.3892/or.2013.2671. Epub 2013 Aug 20. Oncol Rep. 2013. PMID: 23969950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters